You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
SBIR Phase I: Development of a novel graft to provide safe and reliable vascular access for hemodialysis patients
SBC: Innavasc Medical, Inc. Topic: MDThis SBIR Phase I project will advance the development of a novel arteriovenous graft that will minimize injury and decrease the probability of serious complications for chronic hemodialysis patients. Hemodialysis is a life-sustaining therapy for patients suffering from kidney failure; it requires that blood be withdrawn and cycled through a dialysis machine that performs the function of the faile ...
SBIR Phase I 2019 National Science Foundation -
SBIR Phase I: Transforming Complex Utility Transaction Management
SBC: ENERGYXCHAIN LLC Topic: OTThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is empowering the 68 million U.S. natural gas consumers to know their transaction status in real time, have more and continual control of their transactions, settle transactions in increments less than the industry?s current monthly accounting cycle and enjoy an extremely high level of security. Their ...
SBIR Phase I 2019 National Science Foundation -
SBIR Phase I: Engineering broad-spectrum disease resistance in soybean without fitness cost
SBC: UPSTREAM BIOTECHNOLOGY INC Topic: BTThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to develop disease resistant soybean varieties that will reduce the substantial losses in agricultural production caused by plant diseases. Loss to disease can be as high as 40% globally and cost billions of dollars annually. In soybean alone, an estimated $3 billion dollars of production value is ...
SBIR Phase I 2019 National Science Foundation -
SBIR Phase I: Antibacterial Nanotopography for Orthopedic Fixation Devices
SBC: Tyber Medical LLC Topic: BMThis SBIR Phase I project addresses the unacceptable incidence of orthopedic device-related infections, as well as the dangerous rise of antibiotic resistant bacteria. More than 100,000 implanted orthopedic fixation devices (pins, plates, and screws) acquire bacterial infections each year in the US, accounting for approximately $1.5 trillion in associated medical and surgical treatment costs. Furt ...
SBIR Phase I 2019 National Science Foundation -
SBIR Phase I: Non-Chromatographic Method for the Purification of Monoclonal Antibodies
SBC: ISOLERE BIO INC Topic: BTThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to improve manufacturing technology for the purification of monoclonal antibodies, which are important therapeutics as well as valuable tools in research and diagnostics. Approximately four new antibody drugs are approved every year, and while they can have tremendous clinical outcomes and are some ...
SBIR Phase I 2019 National Science Foundation -
SBIR Phase I: Progeny Analysis Of A Chimera-Free Hypoallergenic Peanut
SBC: IngateyGen LLC Topic: BTThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop a hypo allergenic peanut (HAP) variety, which is expected to save human lives by preventing allergy-related deaths, reduce the incidence of peanut allergy, and increase security, comfort and peace of mind for those individuals sensitive to peanuts and their families, extended fam ...
SBIR Phase I 2019 National Science Foundation -
SBIR Phase I: Chemically Resistant Membranes for Water Purification
SBC: NALA MEMBRANES INC Topic: CTThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) project will provide new opportunities for purifying waters that cannot be economically treated using existing commercial membranes. Increased market growth to include recycle and re-use of contaminated water that is currently slated for disposal or long term environmentally risky storage will increase water ...
SBIR Phase I 2019 National Science Foundation -
SBIR Phase I: Interactive Podcast Platform For Listening Comprehension
SBC: Tinkercast, LLC Topic: EAThis Small Business Innovation Research (SBIR) Phase I project intends to enhance listening comprehension skills via an innovative interactive learning platform that aligns with Common Core State Standards for listening comprehension and uses best practices in game-based learning. In 2017, 63% of U.S. 4th graders were reading below proficiency. Improving a students' level of listening comprehensio ...
SBIR Phase I 2019 National Science Foundation -
STTR Phase I: Tuned Miniaturized Point-Field Detectors as Contactless Current Sensor for Post-silicon Power Electronics
SBC: Telli Technologies Inc Topic: EWThe broader impact/commercial potential of this project is to introduce a fully integrated current sensor with an order of magnitude performance improvement over state-of-the-art technologies. The developed technology will enable more reliable, efficient and compact power electronics systems. Power electronics is an integral part of today's power delivery systems such as renewable energy systems, ...
STTR Phase I 2019 National Science Foundation -
STTR Phase I: Sustained Delivery of Peptides with Inverse Flash Nanoprecipitation
SBC: Optimeos Life Sciences, Inc. Topic: BMThis STTR Phase I project aims to pioneer a novel approach for the sustained delivery of peptide therapeutics using nano-composite microparticles. Peptide therapeutics tend to suffer from rapid enzymatic degradation and clearance, with half-lives on the order of minutes, and require frequent injections. The goal of a sustained release formulation is to reduce the frequency of injections by slowly ...
STTR Phase I 2019 National Science Foundation